… the psychedelic medicine conversation looks … drugs than psychedelic therapies. If those findings hold up in larger trials, Delix … acquired Gilgamesh Pharmaceuticals. Gilgamesh had … treatments that act quickly, last longer than conventional antidepressants …

… Drug Administration cleared Delix’s IND submission and approved a Phase II trial … neuroplastogens intended for potential treatment of neuropsychiatric conditions.” … neuroplastogens. Demonstrating rapid, durable antidepressant effects — along with favorable …

… the science and politics driving biotech today? Sign up to … get our biotech newsletter in your inbox. … home Delix Therapeutics, which is developing a psychedelic-like drug for … its next trial, the FDA will allow patients to take the drug — designed …

… and doctors, not … pill. It’s hard to hard who is on the real drug … medication. The next generation of anti-inflammatory treatments … Delix Therapeutics, an American pharmaceuticals company. These experimental drugs show responses indicating antidepressant …

UC Davis Health’s Investing in the Future of Medicine Fund has made its first investment, backing Delix Therapeutics, a neuroscience company developing treatments for depression and other mental health conditions.

… Future of Medicine (IFM) Fund, backing Delix Therapeutics. Delix, a UC … . Now in clinical trials, Delix’s lead candidate DLX … access to these transformative treatments and improve outcomes for … bring patients FDA-approved, take-home medicines that are …

… next generation of neuropsychiatric drug innovation. On June … — including competitors like Delix and Gilgamesh — are advancing … that next-generation neuropsychiatric treatments will likely hinge … If validated through future trials, it could ultimately help …

… the drug was regulated after use raised significant medical concerns. … of psychedelics as new treatments. However, as David Olson … starting points to make better medicines,” says Olson. “We … chief innovation officer of Delix Therapeutics, a company that …

… and outperformed ketamine in antidepressant potency — all while … psychedelic drug LSD. Drugs like JRT might enable new treatments for … chief innovation officer of Delix Therapeutics, a company … Najafi Research Award in Medicinal Chemistry, the Boone Family …